HPV is a commonly occurring virus that is transmitted via skin to skin contact and affects nearly all people at some point in their lives. The good news is that there is an FDA approved vaccine to prevent this virus which can lead to various types of cancers including cervical, oral, and anal. Vaccination against human papillomavirus (HPV) is routinely recommended at age 11 or 12 years for both boys and girls (CDC, 2019). Catch-up recommendations apply to persons not vaccinated at age 11 or 12 years. Catch-up HPV vaccination is now recommended for all persons through age 26 years. For adults aged 27 through 45 years, public health benefit of HPV vaccination in this age range is minimal; shared clinical decision-making is recommended because some persons who are not adequately vaccinated might benefit (CDC, 2019)
Below are some resources regarding the HPV vaccine which is marketed under the names Guardasil and Cervarix.